1. Home
  2. BHVN vs SIBN Comparison

BHVN vs SIBN Comparison

Compare BHVN & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.04

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$17.06

Market Cap

886.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
SIBN
Founded
2013
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
886.9M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
BHVN
SIBN
Price
$13.04
$17.06
Analyst Decision
Buy
Strong Buy
Analyst Count
15
7
Target Price
$29.43
$25.57
AVG Volume (30 Days)
3.7M
561.7K
Earning Date
03-02-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,578,000.00
Revenue This Year
N/A
$21.54
Revenue Next Year
N/A
$15.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.27
52 Week Low
$7.48
$12.50
52 Week High
$44.28
$21.89

Technical Indicators

Market Signals
Indicator
BHVN
SIBN
Relative Strength Index (RSI) 62.98 33.61
Support Level $10.35 $17.01
Resistance Level $12.87 $21.89
Average True Range (ATR) 1.25 0.92
MACD 0.20 -0.45
Stochastic Oscillator 96.61 4.08

Price Performance

Historical Comparison
BHVN
SIBN

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: